NDC 58177-264 - Buspirone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58177-264
- Package NDCs from labels
- 58177-264-04, 58177-264-08
- Manufacturer
- ETHEX
- Effective date
- 2007-04-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Buspirone Hydrochloride - ETHEX | ETHEX | 2007-04-18 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58177-264-04 | Buspirone Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 58177-264-08 | Buspirone Hydrochloride | 500 in 1 BOTTLE | TABLET | 500 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | bee0edbf-3fc3-484b-9715-f13a329216ae | 2025-11-03 | Warnings, Adverse reactions | 866094 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 4e7640d1-0a31-4f97-82bb-574cf1ff6e4a | 2025-10-28 | Warnings, Adverse reactions | 866083 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 40d5813d-d040-002c-e063-6294a90a5f7a | 2025-10-10 | Warnings, Adverse reactions | 866083 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | 7c7225a0-8237-4998-843a-bf10fa6ec65b | 2025-10-09 | Warnings, Adverse reactions | 866094 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Accord Healthcare Inc. | 3da22999-f5fb-49fd-acde-c3006598e985 | 2025-10-07 | Warnings, Adverse reactions | 866083 866094 866018 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 2df0b238-14a4-40ca-a235-411f6c9b8338 | 2025-10-06 | Warnings, Adverse reactions | 866094 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | f85b59b7-b945-4440-8378-987bd287a655 | 2025-10-01 | Warnings, Adverse reactions | 866018 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | b217f341-7d51-475d-887f-f16786164c7b | 2025-10-01 | Warnings, Adverse reactions | 866083 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 270398a0-21b8-407b-af76-4aeef90f72be | 2025-10-01 | Warnings, Adverse reactions | 866018 |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Radha Pharmaceuticals, Inc. | 3f66a3fe-9d73-180c-e063-6394a90aacca | 2025-09-22 | Warnings, Adverse reactions | 866083 866094 866018 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3dd7f213-afd8-67d6-e063-6294a90ac108 | 2025-09-08 | Warnings, Adverse reactions | 866094 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 65c69118-36bb-4f0d-9669-b52556056ec5 | 2025-09-04 | Warnings, Adverse reactions | 866018 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | ed7e334a-cc4a-47b2-a4db-56495730b698 | 2025-09-03 | Warnings, Adverse reactions | 866094 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 5d93a30e-3544-44e7-ab6a-dc9dc79d7c71 | 2025-09-03 | Warnings, Adverse reactions | 866094 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Strides Pharma Science Limited | cff9f09a-1ea2-4968-b57b-e62bebaae238 | 2025-09-02 | Warnings, Adverse reactions | 866083 866094 866018 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 1790d63d-ecb1-da9d-e063-6294a90a50ba | 2025-08-19 | Warnings, Adverse reactions | 866094 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Oxford Pharmaceuticals, LLC | 97fcebc1-6615-4b9d-b0f3-6434850f407c | 2025-08-14 | Warnings, Adverse reactions | 866083 866094 866018 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 3b41fd76-c3cc-77f0-e063-6294a90aa778 | 2025-07-31 | Warnings, Adverse reactions | 866083 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Mylan Institutional Inc. | 91bb5fc9-5121-43c2-b2af-149240d4189a | 2025-07-18 | Warnings, Adverse reactions | 866083 866094 866018 |
| Buspirone HCL | BUSPIRONE HCL | Direct_Rx | 3246dd4d-f787-2f62-e063-6294a90a9cd2 | 2025-06-25 | Warnings, Adverse reactions | 866018 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.